FUJIFILM expands healthcare IT portfolio at SIIM 2015

Stamford, C.T., May 28, 2015 (Booth#237) – FUJIFILM Medical Systems U.S.A., Inc. continues to expand its healthcare IT portfolio, and is taking Vendor Neutral Archive (VNA) into new areas with its latest acquisition of TeraMedica, Inc., by further enhancing the patient imaging record at the 2015 annual meeting of the Society for Imaging Informatics in Medicine (SIIM) on May 28 – May 30 in Washington, D.C.

“Fujifilm recognizes that VNA technology is becoming more important to the market,” said Jim Morgan, vice president of Medical Informatics at FUJIFILM Medical Systems U.S.A., Inc. “Healthcare institutions and market shifts have created larger networks of facilities. Large hospital groups are coming together, disparate PAC systems are more common, and the use of electronic medical records has created central repositories of textual information. But what hospitals also want is to create a single repository for all their imaging data, in addition to other items like lab reports.”

Today, VNA technology serves a growing number of forward-thinking healthcare enterprises around the world to realize the promise of truly integrated patient-centric healthcare. Achieving this across multiple health care applications as well as IT systems and providers, it plays a crucial role in placing healthcare enterprises on the road to meaningful use. In addition to Synapse VNA, following is a summary of Fujifilm offerings:

The cornerstone of Fujifilm’s integrated solution is Synapse PACS. Two main goals – enhanced communication and optimized productivity for radiologists in any imaging environment – were the impetus behind its development.

The next generation of Synapse RIS, the most advanced Radiology Information System on the market today, will also be shown. Synapse RIS and PACS integrate seamlessly, allowing the radiologist to see scanned documents and history from within the PACS, and allowing the user to see images from within the RIS. 

A VNA solution is not complete without an enterprise viewer capable of displaying all of the image types stored to the VNA, with the appropriate tools based on the viewing physician type or department, and ZERO PC requirements. Fujifilm will also showcase its Synapse Mobility Enterprise Viewer to expand VNA image access across entire health system.

For more information, please visit: www.fujimed.com.

About Fujifilm 
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visitwww.fujimed.com and www.fujifilmendoscopy.com.

FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies.  In the year ended March 31, 2014, the company had global revenues of $23.9 billion, at an exchange rate of 102 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.

###

All product and company names herein may be trademarks of their registered owners.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.